Richard S. Geary - 28 Aug 2024 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Signature
By: Patrick R. O'Neil, attorney-in-fact For: Richard S. Geary
Issuer symbol
IONS
Transactions as of
28 Aug 2024
Net transactions value
-$32,159
Form type
4
Filing time
03 Sep 2024, 19:18:03 UTC
Previous filing
06 Aug 2024
Next filing
04 Sep 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Sale $15,731 -320 -0.37% $49.16 85,154 28 Aug 2024 Direct F1
transaction IONS Common Stock Sale $16,428 -331 -0.39% $49.63 84,823 29 Aug 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on April 8, 2024.